Study identifies first drug therapy for sleep apnea
health.ucsd.edu
health.ucsd.edu
“ Funding support for the study came, in part, from Eli Lilly and Company.
Disclosure: Atul Malhotra serves as a consultant to Eli Lilly and Company.”
And from Lilly.com: “ Mounjaro® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.”
Key multiplicity-controlled secondary end points included the percent change in AHI and body weight and changes in hypoxic burden, patient-reported sleep impairment and disturbance, high-sensitivity C-reactive protein (hsCRP) concentration, and systolic blood pressure.
hmm... good?(honestly, I could more easily imagine an exercise pill)
Yes I know it says it right below it.